Last reviewed · How we verify
NCT07371962: Sound Bite
Sound Bite-- a Therapeutic Song-writing Program
NA trial testing therapeutic song-writing program in Depression in 120 participants. Currently enrolling.
31 August 2027
Quick facts
| Lead sponsor | City University of Hong Kong |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 17 February 2026 |
| Primary completion | 31 August 2027 |
| Estimated completion | 31 October 2027 |
| Sites | 1 location across Hong Kong |
Drugs / interventions tested
- therapeutic song-writing program
- Waitlist control group
Conditions studied
- Depression — all drugs for Depression →
Sponsor
City University of Hong Kong
Who can join
Adults 13 to 24, any sex, with Depression. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The research aims to investigate the effectiveness of the therapeutic song-writing program on young people with depressive symptoms. This study adopts a multicentre randomized control trial two arms research design. A randomised controlled trial will compare a typical 7-session therapeutic song-writing program with a waitlist-control group to determine whether the 7-session therapeutic song-writing program can produce better outcomes for young people with depressive symptoms, including improvement in depressive symptoms, self-stigma, self-esteem, sense of hope and social support at post-intervention. The 7-session therapeutic song-writing program will be delivered by trained and experienced social workers and helping professionals who are familiar with music therapy. A research staff, who does not involve in the group allocation and delivery of group intervention, conduct the intervention outcomes assessment of the participants before and after the intervention. Standardized assessment tools are used to assess the intervention outcomes. The ethical considerations of this study were reviewed and approved by the Human and Artefacts Ethics Sub-Committee of the City University of Hong Kong in 2025.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07371962
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Depression
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT07517549 — Sexual Health Education During Pregnancy · NA · recruiting
- NCT06408246 — ACE-D Aim 3 Clinical Cognitive Trial to Enhance Translation in Depression · Phase 2 · recruiting
- NCT07449676 — Effects of an Innovative TCM-based Tui Jing Therapy on Psychological and Neurophysiological Functions in Depression · NA · recruiting
Other City University of Hong Kong trials
Trials by the same sponsor.
- NCT07374653 — Online Self-healing Program · NA · not yet recruiting
- NCT07392632 — MindfulCityU-- A Mindfulness Mobile Application for Promoting University Students' Mental Health · NA · not yet recruiting
- NCT07372066 — Cognitive Stimulation Therapy Group for Residential Home Residents With Dementia and Mild Cognitive Impairment · NA · recruiting
- NCT07371988 — Efficacy of Narrative Therapy for Older People With Depression · NA · recruiting
- NCT06639932 — We-INtervention Among Chinese HIV-serodiscordant Male Couples · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07371962 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by City University of Hong Kong
- Last refreshed: 9 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07371962.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing